FERTINEX
LOE Approachingurofollitropin
NDASUBCUTANEOUSINJECTABLE
Approved
Sep 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
2/8 — Basic
Drug data last refreshed 19h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FERTINEX (urofollitropin) is a urinary-derived follicle-stimulating hormone (FSH) indicated for ovulation induction and assisted reproductive technologies. Administered via subcutaneous injection, it stimulates follicular development in women with infertility. The drug treats patients undergoing fertility treatment protocols.
LOE Approaching
As LOE approaches, the brand team is likely contracting; opportunities exist in generics transition planning and lifecycle extension strategies rather than growth-focused roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females
Started Oct 2013
215 enrolled
Anovulation
Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program
Started Oct 2013
263 enrolled
Infertility
Career Relevance
Working on FERTINEX offers limited career growth opportunity given the LOE-approaching lifecycle stage and minimal linked job openings. Roles are defensive in nature, focused on market protection and generic transition rather than expansion or innovation.
Brand Manager
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.